I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Epperla, N
76
results:
Search for persons
X
Format
Online (76)
Mediatypes
Articles (Online) (46)
Bookchapter (Online) (1)
OpenAccess-fulltext (29)
Sorted by: Relevance
Sorted by: Year
?
1
IMMUNOTHERAPY ALONE VERSUS CHEMOIMMUNOTHERAPY AS FIRST‐LINE..:
Olszewski, A. J.
;
Epperla, N.
;
Chihara, D.
.
Hematological Oncology. 41 (2023) S2 - p. 107-108 , 2023
Link:
https://doi.org/10.1002/..
?
2
Brentuximab vedotin (BV) + AVD for newly diagnosed classic ..:
Bowers, J. T.
;
Anna, J.
;
Bair, S. M.
...
Hematological Oncology. 41 (2023) S2 - p. 359-360 , 2023
Link:
https://doi.org/10.1002/..
?
3
Outcomes in primary gastrointestinal (GI) follicular lympho..:
St‐Pierre, F.
;
Alrifai, T.
;
Alhamad, K.
...
Hematological Oncology. 41 (2023) S2 - p. 380-381 , 2023
Link:
https://doi.org/10.1002/..
?
4
Combination of the PD‐1 inhibitor Nivolumab and Immunomodul..:
Bond, D. A.
;
Wei, L.
;
Yildiz, V.
...
Hematological Oncology. 41 (2023) S2 - p. 597-598 , 2023
Link:
https://doi.org/10.1002/..
?
5
A SINGLE‐CENTER RETROSPECTIVE ANALYSIS OF THE TOXICITY OF H..:
Fleming, M
;
Huang, Y
;
Dotson, E
...
Hematological Oncology. 39 (2021) S2 - p. , 2021
Link:
https://doi.org/10.1002/..
?
6
SURVIVAL FOLLOWING FIRST RELAPSE IN YOUNGER PATIENTS WITH M..:
Karmali, R.
;
Donovan, A.
;
Wagner‐Johntson, N.
...
Hematological Oncology. 39 (2021) S2 - p. , 2021
Link:
https://doi.org/10.1002/..
?
7
OUTCOMES FOR PATIENTS WITH MANTLE CELL LYMPHOMA EXPERIENCIN..:
Bond, D.A.
;
Switchenko, J.
;
Maddocks, K.
...
Hematological Oncology. 37 (2019) S2 - p. 408-410 , 2019
Link:
https://doi.org/10.1002/..
?
8
PHASE I DOSE‐ESCALATION STUDY OF VENETOCLAX PLUS BEAM FOLLO..:
Maakaron, J.
;
Zhao, Q.
;
Puto, M.
...
Hematological Oncology. 37 (2019) S2 - p. 528-529 , 2019
Link:
https://doi.org/10.1002/..
?
9
MAINTENANCE RITUXIMAB IS ASSOCIATED WITH IMPROVED OVERALL S..:
Hill, B.T.
;
Switchenko, J.M.
;
Martin, P.
...
Hematological Oncology. 37 (2019) S2 - p. 405-407 , 2019
Link:
https://doi.org/10.1002/..
?
10
A PHASE II TRIAL OF BRENTUXIMAB VEDOTIN (BV) AND LENALIDOMI..:
William, B.M.
;
Abbasi, A.
;
Huang, Y.
...
Hematological Oncology. 37 (2019) S2 - p. 471-472 , 2019
Link:
https://doi.org/10.1002/..
?
11
Salvage haploidentical hematopoietic cell transplantation f..:
Epperla, N
;
Pasquini, M
;
Pierce, K
...
Bone Marrow Transplantation. 52 (2016) 1 - p. 147-150 , 2016
Link:
https://doi.org/10.1038/..
?
12
Impact of haploidentical hematopoietic cell transplantation..:
Raj, R V
;
Hari, P
;
Pasquini, M
...
Bone Marrow Transplantation. 51 (2016) 12 - p. 1602-1604 , 2016
Link:
https://doi.org/10.1038/..
?
13
An international analysis evaluating frontline bendamustine..:
Alderuccio J. P
;
Arcaini L
;
Watkins M. P
...
info:eu-repo/semantics/altIdentifier/pmid/35196377. , 2022
Link:
http://hdl.handle.net/11..
?
14
Development of a distributed international patient data reg..:
Andritsos, LA
;
Anghelina, M
;
Neal, J
...
issn:1042-8194. , 2022
Link:
http://hdl.handle.net/11..
?
15
Development of a distributed international patient data reg..:
Andritsos L. A
;
Anghelina M
;
Neal J
...
info:eu-repo/semantics/altIdentifier/pmid/36070610. , 2022
Link:
https://hdl.handle.net/1..
1-15